MedPath

Caffeine Increases Maximal Fat Oxidation During Exercise in Endurance-trained Men: is There a Diurnal Variation

Not Applicable
Completed
Conditions
Energy Metabolism
Athletic Performance
Interventions
Behavioral: Test in the morning
Behavioral: Test in the afternoon
Registration Number
NCT04320446
Lead Sponsor
Universidad de Granada
Brief Summary

Maximal fat oxidation during exercise (MFO) and the intensity of exercise that elicits MFO (Fatmax) has been recognized as potential determinants of endurance performance.

The purpose of this study was to determine the possible interaction between the effects of diurnal variation (morning vs. afternoon) and caffeine ingestion on MFO, Fatmax and VO2 max in endurance-trained men. Specifically, the investigators sought to elucidate whether the stimulant actions of caffeine could reverse the decrements of MFO and Fatmax observed in the morning.

Detailed Description

Body weight, height, body composition (DXA), exercise test (MFO and VO2max assessment) will be measured during the 4 evaluations.

Participants were randomized into 4 exercise test conditions:

1. Exercise test in the morning with placebo intake

2. Exercise test in the evening with placebo intake

3. Exercise test in the morning with caffeine intake

4. Execrise test in the evening with caffeine intake

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • Having a body mass index (BMI) ranged from 18.5 to 28 kg/m2
  • not suffering any specific disease which can be aggravated by physical exercise
  • having previous experience in endurance training (i.e. self-reporting at least 2 years of cycling or running training including more than 3 training sessions/week).
  • Participant must be capable and willing to provide consent, understand exclusion criteria, instructions and protocols.
Exclusion Criteria
  • Being smoker
  • Taking medication or drugs
  • Any non-controlled medical condition which could influence results or could be worsened by the participation in the study
  • Are deemed unsuitable by the investigator for any other reason, that prevent data collection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboTest in the afternoonA dose of 3 mg/kg of placebo (i.e. 100% purity microcrystalline cellulose, Acofarma, Spain) was ingested before the beginning of each test.
CaffeineTest in the morningA dose of 3 mg/kg of caffeine (i.e. a vegetable extraction from green coffee beans, Harrison Sport Nutrition®, Spain) was ingested before the beginning of each test.
CaffeineTest in the afternoonA dose of 3 mg/kg of caffeine (i.e. a vegetable extraction from green coffee beans, Harrison Sport Nutrition®, Spain) was ingested before the beginning of each test.
PlaceboTest in the morningA dose of 3 mg/kg of placebo (i.e. 100% purity microcrystalline cellulose, Acofarma, Spain) was ingested before the beginning of each test.
Primary Outcome Measures
NameTimeMethod
MFOThrough study completion, an average of 1 month

Maximal fat oxidation during exercise

Secondary Outcome Measures
NameTimeMethod
FATmaxThrough study completion, an average of 1 month

The intensity of exercise that elicits MFO

VO2maxThrough study completion, an average of 1 month

Cardiorrespiratory fitness measured by maximal oxygen uptake

Trial Locations

Locations (1)

Instituto Mixto Universitario Deporte Salud

🇪🇸

Granada, Spain

© Copyright 2025. All Rights Reserved by MedPath